J. Chen et al., A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma, CARCINOGENE, 19(12), 1998, pp. 2129-2132
We examined the relationship between a functional polymorphism (C-667-->T,
ala-->val) of the methylenetetrahydrofolate reductase gene (MTHFR) and the
risk of colorectal adenomas in the prospective Nurses' Health Study. Among
257 incident polyp cases and 713 controls, the MTHFR val/val polymorphism [
relative risk (RR) = 1.35, 95% confidence interval (CI) 0.84-2.17] was not
significantly associated with risk of adenomas, This lack of association wa
s observed for both small (RR = 1.36, 95% CI 0.76-2.45) and large (RR = 1.3
2, 95% CI 0.66-2.66) adenomas, Furthermore, there was no significant intera
ction between this polymorphism and consumption of either folate, methionin
e or alcohol. We also examined the relationship of a newly identified polym
orphism (asp919gly) of the methionine synthase gene (MS) with the risk of c
olorectal adenomas in the same population. The MS gly/gly polymorphism was
also not significantly associated with risk of colorectal adenomas (RR = 0.
66, 95% CI 0.26-1.70). These results, which need to be confirmed in other s
tudies, suggest that the MTHFR val/val polymorphism, which has been previou
sly inversely associated with risk of colorectal cancer, plays a role only
in a late stage (adenoma-->carcinoma) of colorectal tumorigenesis, and/or m
ay protect against malignant transformation in the subset of benign adenoma
s, which may progress to malignancy.